Moreover, TCGA analysis revealed that CISAL-BRCA1 axis is associated with OS in multiple types of cancers, suggesting that CISAL-BRCA1 axis could be used as a target to predict or improve neoadjuvant chemosensitivity and patients' overall survival. This evidence concerns the gene BRCA1 and cancer.